Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Straumann (STMN.S)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (CHF) Price Target (CHF) Rating
2022-02-21140.20187.50Neutral
2022-02-22144.45152.00Neutral
2022-05-02115.75125.00Neutral
2022-09-14100.7596.75Sell
2022-11-28109.3596.00Sell
2023-02-23127.95126.00Neutral
2023-06-23137.75138.00Neutral
2023-11-01105.60110.00Neutral
2024-02-29139.60148.00Neutral
2024-06-27113.65120.00Neutral
2024-08-16124.80113.00Sell
2024-10-30115.50107.00Sell
2025-02-20132.50108.00Sell
2025-04-1695.5095.00Sell
2025-05-02104.4596.00Sell

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
  • UBS Fund Management (Switzerland) AG beneficially owns more than 5% of the total issued share capital of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.